Risk of Diarrhea with Low‑Dose Macrogol (PEG 3350) and Management Strategies

Mechanism of Action

Macrogol 3350 exerts an osmotic effect that sequesters fluid in the intestinal lumen, softening stool and increasing water content; when the dose exceeds individual tolerance, loose, watery stools occur as a pharmacologic effect rather than an adverse reaction. 1
The distinction between therapeutic softening and clinically significant diarrhea depends on stool frequency and consistency relative to the patient’s baseline, with excess frequency or watery consistency indicating overt diarrhea. 1

Elderly patients are especially vulnerable because adequate fluid intake is required for macrogol to work; insufficient intake can paradoxically cause both treatment failure and excessive fluid shift into the bowel, raising diarrhea risk. 4
In non‑ambulatory patients with low fluid intake, non‑absorbable soluble fiber or bulk agents should be avoided due to obstruction risk, and the same precaution applies to osmotic laxatives such as macrogol. 4

The typical maintenance dose in children is 0.7–0.8 g/kg/day, but individual tolerance varies widely, and even standard doses can cause diarrhea in volume‑depleted or elderly‑like patients. 5
The American Academy of Pediatrics notes that insufficient liquid intake is a common cause of treatment failure, and in volume‑depleted patients even standard macrogol doses may produce excessive osmotic effect. 5

Co‑administration of prokinetic agents (e.g., prucalopride, parasympathomimetics) that commonly cause diarrhea adds to the osmotic effect of macrogol, markedly increasing the likelihood of diarrhea. 1
Before initiating macrogol, clinicians should review concurrent medications for pro‑kinetic activity (e.g., metoclopramide, erythromycin) and consider dose reduction or alternative timing to mitigate additive diarrhea risk. 1

For elderly patients, start with the lowest effective dose (e.g., 13.8 g once daily) rather than the standard twice‑daily regimen, and titrate based on stool response. 4
Ensure patients consume at least 1.5–2 L of fluid daily (beyond the mixing liquid) when using macrogol to reduce the chance of excessive osmotic load. 5

Monitor patients within 24–48 hours for >3–4 loose stools per day, watery consistency, or loss of bowel control, which signal an excessive osmotic effect requiring dose adjustment. 6
If diarrhea develops, reduce the macrogol dose by approximately 50 % or temporarily hold the medication while maintaining adequate hydration. [5][7]

Transient abdominal distension, flatulence, and nausea are common but usually mild and resolve within a few days as the bowel adapts. [5][7]
In elderly patients on diuretics or cardiac glycosides, monitor electrolytes because diarrhea can precipitate dehydration and electrolyte disturbances. 4
Macrogol is contraindicated in patients with bowel obstruction or paralytic ileus; these conditions must be excluded before therapy. 5